HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU A
Jak stosować HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU A
Tłumaczenie AI
Ta strona ma charakter informacyjny i nie zastępuje konsultacji lekarskiej. Przed zastosowaniem jakiegokolwiek leku skonsultuj się z lekarzem. Jeśli objawy są poważne, skorzystaj z pilnej pomocy medycznej.
Pokaż oryginałINSTRUCTIONS for medical use of the medicinal product PUSTYRNICA TINCTURE
Composition
The active substance: 1 vial contains a tincture of motherwort herb (Leonuri herba) (1:5) (extractant - 70% ethanol) - 25 ml;
Pharmaceutical form
Tincture.
Main physical and chemical properties
A clear liquid of greenish-brown color with a specific odor.
Pharmacotherapeutic group
Sedatives and anxiolytics.
ATC code N05C M.
Pharmacological properties
The preparation has a sedative effect. Biologically active substances contained in motherwort herb (steroid and flavonoid glycosides, essential oil, stachydrine, alkaloid leopurin, saponins, tannins) enhance the process of inhibition or reduce the process of excitation in the central nervous system. It does not have a hypnotic effect, but facilitates the onset of physiological sleep and deepens it. It does not cause addiction or psychological dependence.
Clinical characteristics
Indications
Functional disorders of the cardiovascular system (neurocirculatory dystonia of the hypertensive type), initial stages of arterial hypertension, as well as increased emotional excitability, irritability, and mild sleep disorders.
Contraindications
Expressed arterial hypotension (reduced arterial pressure), bradycardia. Increased individual hypersensitivity to the components of the preparation.
Special safety measures
It is not recommended to use the preparation for a long time due to the content of ethanol.
Interaction with other medicinal products and other types of interactions
Motherwort tincture can potentiate the pharmacological effects of sedatives, hypnotics, analgesics, antihypertensive drugs, and cardiac glycosides, as well as enhance the effect of alcohol.
When using any other medicinal products, you should inform your doctor.
Features of application
Use during pregnancy or breastfeeding
Since the preparation contains ethanol, the tincture should not be taken by women during pregnancy and breastfeeding.
Ability to affect the speed of reaction when driving or working with other mechanisms
When using the preparation, you should refrain from potentially hazardous activities that require increased attention (driving, working with mechanisms).
Method of application and doses
Motherwort tincture is taken orally after meals.
Adults are prescribed 30-50 drops of tincture 3-4 times a day, children over 12 years old - 1 drop of tincture per 1 year of life.
The duration of the treatment course is determined individually for each patient, taking into account the nature, severity of the pathological process, characteristics of the disease, tolerance to the preparation, and stability of the achieved therapeutic effect.
Children
Do not use internally for children under 12 years old due to the content of ethanol.
Overdose
When exceeding the recommended doses of the preparation, dizziness, drowsiness, decreased arterial pressure, and possible development of increased sensitivity to the preparation may be observed.
In case of overdose, you should stop using the preparation and take immediate measures of symptomatic and supportive therapy (according to the patient's clinical condition).
Adverse reactions
With individual increased sensitivity to the preparation, the development of allergic reactions (including redness and swelling of the skin, rash, itching) is possible, as well as dizziness, drowsiness, feeling of fatigue, decreased mental and physical performance.
Shelf life
4 years.
Storage conditions
Store in the original packaging at a temperature not exceeding 25°C.
Store in a place inaccessible to children.
Packaging
25 ml in vials.
Release category
Without a prescription.
Manufacturer
PRAT "FITOFARM".
Location of the manufacturer and its address
Ukraine, 84500, Donetsk region, Bakhmut, Sibirceva street, 2.
Applicant
PRAT "FITOFARM".
Location of the applicant
Ukraine, 02092, Kyiv, Almatynska street, building 12.
- Kraj rejestracji
- Substancja czynna
- Wymaga receptyTak
- Producent
- Te treści mają charakter wyłącznie informacyjny i nie zastępują konsultacji lekarskiej.
- Zamienniki HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU APostać farmaceutyczna: suspension, 720 ELISA units; 0.5 ml (1 dose)Substancja czynna: hepatitis A, inactivated, whole virusProducent: ГлаксоСмітКляйн Біолоджікалз С.А.Wymaga receptyPostać farmaceutyczna: suspension, 20 mcg/1 ml, 0.5 mlSubstancja czynna: hepatitis B, purified antigenProducent: ГлаксоСмітКляйн Біолоджікалз С.А.Wymaga receptyPostać farmaceutyczna: suspension, 10 mcg/dose 0.5 mlSubstancja czynna: hepatitis B, purified antigenProducent: ЕлДжі Кем, Лтд.Wymaga recepty
Odpowiedniki HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU A w innych krajach
Leki z tą samą substancją czynną dostępne w innych krajach.
Odpowiednik HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU A w Polska
Lekarze online w sprawie HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU A
Omów stosowanie HAVRIKS 1440 VAKCINA DLA PROFILAKTIKI GEPATITU A, bezpieczeństwo i ocenę zasadności recepty zgodnie z obowiązującymi przepisami.
Często zadawane pytania
Bądź na bieżąco z Oladoctor
Informacje o nowych usługach, aktualizacjach produktu i przydatnych materiałach dla pacjentów.